Monday, March 30, 2020 4:45:14 PM
Henry Schein NASD HSIC CEO
No Clinical Data
On Rapid Pin Prick Rapid Antibody test
Not FDA Approved
No price set (will be inexpensive)
Made in USA
Hope to launch 100k units to Health care providers
Hope to ramp to millions
Working with multiple manufacturers
Web Site https://www.henryschein.com/us-en/corporate/coronavirus.aspx?utm_source=Corporate&utm_medium=External&utm_campaign=20200314VanityURL&utm_term=COVID19update&cdivid=Corporate
*NOTE* My Posts on iHub are NOT Investment Advice / ALWAYS consult a Licensed Professional for Investments and/or Trading
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM